Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

336.74 +0.74 (+0.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
60 61 Next >
News headline image
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024 ↗
There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024. 
Via The Motley Fool
Topics Stocks
News headline image
Amgen's Options: A Look at What the Big Money is Thinking ↗
 
Via Benzinga
News headline image
Full Approval For Amgen's Flagship Cancer Drug Lumakras Pushed For Around Four Years ↗
Amgen Inc (NASDAQ: AMGN) announced that the FDA has reviewed the company's supplemental New Drug Application, seeking full approval of the KRAS-blocking drug  
Via Benzinga
News headline image
Analyzing Amgen In Comparison To Competitors In Biotechnology Industry ↗
 
Via Benzinga
News headline image
Is NASDAQ:AMGN a Good Fit for Dividend Investing? ↗
Why AMGEN INC (NASDAQ:AMGN) is a Top Pick for Dividend Investors. 
Via Chartmill
News headline image
Spotlight on Amgen: Analyzing the Surge in Options Activity ↗
 
Via Benzinga
News headline image
Looking Into Amgen's Recent Short Interest ↗
 
Via Benzinga
News headline image
In-Depth Examination Of 18 Analyst Recommendations For Amgen ↗
 
Via Benzinga
News headline image
Is Amgen Stock a Buy Now? ↗
Boring businesses can be successful, too. 
Via The Motley Fool
News headline image
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’ ↗
It's now time to take a look at these three biotech stocks to buy, as each one is currently within TradeSmith's "Green Zone." 
Via InvestorPlace
News headline image
CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief ↗
The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy. 
Via InvestorPlace
News headline image
Amgen Provides Exposure To Obesity Drug At A Reasonable Price, Says Bullish Analyst ↗
Amgen, Inc. (NASDAQ: AMGN) shares have been in focus amid developments in the AI-powered healthcare space. 
Via Benzinga
News headline image
Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Healthcare Sector Stocks: Consistent Above-Average Growth And Income ↗
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records. 
Via Talk Markets
News headline image
Market Whales and Their Recent Bets on AMGN Options ↗
 
Via Benzinga
News headline image
Insights Into Amgen's Performance Versus Peers In Biotechnology Sector ↗
 
Via Benzinga
News headline image
P/E Ratio Insights for Amgen ↗
 
Via Benzinga
News headline image
1 Biotech Stock That Could Be the Next Amgen ↗
The emergence of genomic medicine as a viable modality could transform this midcap biotech into the next Amgen. 
Via The Motley Fool
News headline image
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics? ↗
Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint. 
Via The Motley Fool
News headline image
PVH To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Looking Into Amgen's Recent Short Interest ↗
 
Via Benzinga
News headline image
Analyst Ratings for Amgen ↗
 
Via Benzinga
News headline image
1 Spectacular Dividend Stock Every Investor Should Consider ↗
This biotech pioneer has been an exceptional growth and income stock. 
Via The Motley Fool
News headline image
Why NASDAQ:AMGN is a Top Pick for Dividend Investors. ↗
Why AMGEN INC (NASDAQ:AMGN) qualifies as a good dividend investing stock. 
Via Chartmill
News headline image
Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors ↗
 
Via Benzinga
News headline image
P/E Ratio Insights for Amgen ↗
 
Via Benzinga
News headline image
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning ↗
Biotech companies are edging closer to finding the answers behind Alzheimer's disease. 
Via Investor's Business Daily
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors ↗
 
Via Benzinga
News headline image
2 Top Biotech Stocks to Buy Right Now ↗
Don't give up on these stocks too fast. 
Via The Motley Fool
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.